Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CareDx, Inc.CDNA · Entity 4344 | Chief Financial Officer | November 03, 2020 | November 04, 2020 |
| Guardant Health, Inc.GH · Entity 3238 | Chief Financial Officer | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CareDx, Inc.
Report date November 03, 2020 · Filed November 04, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 103,343 |
Ending reported balance
After 2020-11-03 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2020-11-03 · Exercise / conversion · Acquired 3,333 · Balance 113,610 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Row 2 · 2020-11-03 · Exercise / conversion · Acquired 12,667 · Balance 126,277 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Row 3 · 2020-11-03 · Exercise / conversion · Acquired 1,168 · Balance 127,445 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Row 4 · 2020-11-03 · Exercise / conversion · Acquired 4,167 · Balance 131,612 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Row 5 · 2020-11-03 · Exercise / conversion · Acquired 3,750 · Balance 135,362 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Row 6 · 2020-11-03 · Exercise / conversion · Acquired 555 · Balance 135,917 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Row 7 · 2020-11-03 · Sale · Disposed 32,574 · Balance 103,343 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $48.00 to $48.85, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2027-04-21 | Direct | 6,667 |
Reported balance
After 2020-11-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-11-03 · Exercise / conversion · Disposed 3,333 · Balance 6,667 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3: 1/4th of the shares subject to the option vested on April 21, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.17 · Expires 2029-02-04 | Direct | 19,333 |
Reported balance
After 2020-11-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-11-03 · Exercise / conversion · Disposed 12,667 · Balance 19,333 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4: 1/4th of the shares subject to the option vested on February 4, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.31 · Expires 2028-01-19 | Direct | 4,963 |
Reported balance
After 2020-11-03 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2020-11-03 · Exercise / conversion · Disposed 1,168 · Balance 4,963 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5: 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.24 · Expires 2028-06-29 | Direct | 21,875 |
Reported balance
After 2020-11-03 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2020-11-03 · Exercise / conversion · Disposed 4,167 · Balance 21,875 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6: 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.90 · Expires 2027-10-27 | Direct | 13,125 |
Reported balance
After 2020-11-03 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2020-11-03 · Exercise / conversion · Disposed 3,750 · Balance 13,125 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7: 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.80 · Expires 2027-09-01 | Direct | 1,667 |
Reported balance
After 2020-11-03 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2020-11-03 · Exercise / conversion · Disposed 555 · Balance 1,667 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8: 50% of the shares subject to the option vested on September 1, 2018 and 1/72nd of the shares subject to the option vest monthly thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $48.00 to $48.85, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
F3: 1/4th of the shares subject to the option vested on April 21, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
F4: 1/4th of the shares subject to the option vested on February 4, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
F5: 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
F6: 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
F7: 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
F8: 50% of the shares subject to the option vested on September 1, 2018 and 1/72nd of the shares subject to the option vest monthly thereafter.
Guardant Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 55,182 |
Ending reported balance
After 2026-10-01 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 2,085 · Balance 53,901 Row 2 · 2026-10-01 · Exercise / conversion · Acquired 3,324 · Balance 57,225 Row 3 · 2026-10-01 · Exercise / conversion · Acquired 1,871 · Balance 59,096 Row 4 · 2026-10-01 · Tax withholding · Disposed 3,914 · Balance 55,182 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-10-01 · Exercise / conversion · Disposed 2,085 · Balance 0 F2: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 13,296 |
Reported balance
After 2026-10-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-10-01 · Exercise / conversion · Disposed 3,324 · Balance 13,296 F4: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 11,222 |
Reported balance
After 2026-10-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-10-01 · Exercise / conversion · Disposed 1,871 · Balance 11,222 F5: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter.
F3: Not applicable for Restricted Stock Units.
F4: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F5: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2022 Filed May 26, 2022 20:13 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 39,454 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001576280-22-000032 · wf-form4_165359596223153.xml · derivative · entry 1 Bell Michael Brian · CIK 0001702824 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,454 Underlying: COMMON STOCK · 39,454 shares Expires 2032-05-09 F1 · derivative.exercise_date: This represents a stock option granted on May 09, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on February 18, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter. Read SEC document |
| January 15, 2022 Filed Jan 18, 2022 21:38 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 3,308 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000004 · wf-form4_164254189903908.xml · derivative · entry 3 Bell Michael Brian · CIK 0001702824 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,926 Underlying: COMMON STOCK · 3,308 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on January 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of January 15, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 15, 2022 Filed Jan 18, 2022 21:38 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 1,246 | $77.58 | $96,664.68 |
DisclosureSEC source: 0001576280-22-000004 · wf-form4_164254189903908.xml · nonDerivative · entry 2 Bell Michael Brian · CIK 0001702824 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,062 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 15, 2022 Filed Jan 18, 2022 21:38 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantCOMMON STOCK | 3,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000004 · wf-form4_164254189903908.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,308 Read SEC document |
| May 04, 2021 Filed May 6, 2021 20:31 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 13,234 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-21-000060 · wf-form4_162033305173617.xml · derivative · entry 2 Bell Michael Brian · CIK 0001702824 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,234 Underlying: COMMON STOCK · 13,234 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on January 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of January 15, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| May 04, 2021 Filed May 6, 2021 20:31 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 26,467 | $0.00 Strike: $148.19 | $0.00 |
DisclosureSEC source: 0001576280-21-000060 · wf-form4_162033305173617.xml · derivative · entry 1 Bell Michael Brian · CIK 0001702824 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,467 Underlying: COMMON STOCK · 26,467 shares Expires 2031-05-03 F1 · derivative.exercise_date: The stock option vests as to 25% of the shares subject to such award on January 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of January 15, 2022, during the three-year period thereafter. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 00:42 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 555 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0001217234-20-000196 · wf-form4_160445054424014.xml · derivative · entry 13 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,667 Underlying: Common Stock · 555 shares Expires 2027-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · derivative.exercise_date: 50% of the shares subject to the option vested on September 1, 2018 and 1/72nd of the shares subject to the option vest monthly thereafter. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 00:42 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,750 | $0.00 Strike: $5.90 | $0.00 |
DisclosureSEC source: 0001217234-20-000196 · wf-form4_160445054424014.xml · derivative · entry 12 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 3,750 shares Expires 2027-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · derivative.exercise_date: 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 00:42 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,167 | $0.00 Strike: $12.24 | $0.00 |
DisclosureSEC source: 0001217234-20-000196 · wf-form4_160445054424014.xml · derivative · entry 11 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,875 Underlying: Common Stock · 4,167 shares Expires 2028-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · derivative.exercise_date: 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 00:42 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,168 | $0.00 Strike: $6.31 | $0.00 |
DisclosureSEC source: 0001217234-20-000196 · wf-form4_160445054424014.xml · derivative · entry 10 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,963 Underlying: Common Stock · 1,168 shares Expires 2028-01-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 00:42 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,667 | $0.00 Strike: $27.17 | $0.00 |
DisclosureSEC source: 0001217234-20-000196 · wf-form4_160445054424014.xml · derivative · entry 9 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,333 Underlying: Common Stock · 12,667 shares Expires 2029-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: 1/4th of the shares subject to the option vested on February 4, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 00:42 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,333 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001217234-20-000196 · wf-form4_160445054424014.xml · derivative · entry 8 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Stock · 3,333 shares Expires 2027-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · derivative.exercise_date: 1/4th of the shares subject to the option vested on April 21, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 00:42 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 32,574 | $48.15 | $1,568,486.96 |
DisclosureSEC source: 0001217234-20-000196 · wf-form4_160445054424014.xml · nonDerivative · entry 7 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,343 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $48.00 to $48.85, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 00:42 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 555 | $2.80 | $1,554.00 |
DisclosureSEC source: 0001217234-20-000196 · wf-form4_160445054424014.xml · nonDerivative · entry 6 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 00:42 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 3,750 | $5.90 | $22,125.00 |
DisclosureSEC source: 0001217234-20-000196 · wf-form4_160445054424014.xml · nonDerivative · entry 5 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 00:42 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 4,167 | $12.24 | $51,004.08 |
DisclosureSEC source: 0001217234-20-000196 · wf-form4_160445054424014.xml · nonDerivative · entry 4 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 00:42 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 1,168 | $6.31 | $7,370.08 |
DisclosureSEC source: 0001217234-20-000196 · wf-form4_160445054424014.xml · nonDerivative · entry 3 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 00:42 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 12,667 | $27.17 | $344,162.39 |
DisclosureSEC source: 0001217234-20-000196 · wf-form4_160445054424014.xml · nonDerivative · entry 2 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 00:42 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 3,333 | $1.00 | $3,333.00 |
DisclosureSEC source: 0001217234-20-000196 · wf-form4_160445054424014.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| August 06, 2020 Filed Aug 7, 2020 22:55 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 619 | $34.65 | $21,448.35 |
DisclosureSEC source: 0001217234-20-000152 · wf-form4_159684032977481.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,277 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units. F2 · balance_after: These shares remain subject to a lock-up agreement entered into among the Reporting Person and the representatives of the underwriters for the Issuer's public offering of common stock completed in June 2020. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 01:32 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $34.49 | $0.00 |
DisclosureSEC source: 0001217234-20-000135 · wf-form4_159417191098931.xml · derivative · entry 2 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-07-06 F2 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on July 6, 2021 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 01:32 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001217234-20-000135 · wf-form4_159417191098931.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,896 F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on July 6, 2021 and 1/4th of which shall vest on each anniversary thereafter. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 15:40 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 6,197 | $32.82 | $203,385.54 |
DisclosureSEC source: 0001217234-20-000078 · wf-form4_159119882528287.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,896 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units. Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:18 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,458 | $12.24 Strike: $12.24 | $140,245.92 |
DisclosureSEC source: 0001217234-20-000061 · wf-form4_158897992025650.xml · derivative · entry 12 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,042 Underlying: Common Stock · 11,458 shares Expires 2028-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · derivative.exercise_date: 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:18 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,211 | $6.31 Strike: $6.31 | $20,261.41 |
DisclosureSEC source: 0001217234-20-000061 · wf-form4_158897992025650.xml · derivative · entry 11 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,131 Underlying: Common Stock · 3,211 shares Expires 2028-01-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:18 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,667 | $2.80 Strike: $2.80 | $4,667.60 |
DisclosureSEC source: 0001217234-20-000061 · wf-form4_158897992025650.xml · derivative · entry 10 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,222 Underlying: Common Stock · 1,667 shares Expires 2027-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · derivative.exercise_date: 50% of the shares subject to the option vested on September 1, 2018 and 1/72nd of the shares subject to the option vest monthly thereafter. Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:18 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,313 | $5.90 Strike: $5.90 | $60,846.70 |
DisclosureSEC source: 0001217234-20-000061 · wf-form4_158897992025650.xml · derivative · entry 9 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,875 Underlying: Common Stock · 10,313 shares Expires 2027-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:18 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,167 | $1.00 Strike: $1.00 | $9,167.00 |
DisclosureSEC source: 0001217234-20-000061 · wf-form4_158897992025650.xml · derivative · entry 8 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 9,167 shares Expires 2027-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: 1/4th of the shares subject to the option vested on April 21, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:18 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 1,429 | $29.58 | $42,270.39 |
DisclosureSEC source: 0001217234-20-000061 · wf-form4_158897992025650.xml · nonDerivative · entry 7 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,093 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $29.55 to $29.63, inclusive. The Reporting Persons undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:18 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 55,707 | $28.99 | $1,614,762.10 |
DisclosureSEC source: 0001217234-20-000061 · wf-form4_158897992025650.xml · nonDerivative · entry 6 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,522 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.49 to $29.48, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:18 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 11,458 | $12.24 | $140,245.92 |
DisclosureSEC source: 0001217234-20-000061 · wf-form4_158897992025650.xml · nonDerivative · entry 5 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:18 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 3,211 | $6.31 | $20,261.41 |
DisclosureSEC source: 0001217234-20-000061 · wf-form4_158897992025650.xml · nonDerivative · entry 4 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:18 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 1,667 | $2.80 | $4,667.60 |
DisclosureSEC source: 0001217234-20-000061 · wf-form4_158897992025650.xml · nonDerivative · entry 3 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:18 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 10,313 | $5.90 | $60,846.70 |
DisclosureSEC source: 0001217234-20-000061 · wf-form4_158897992025650.xml · nonDerivative · entry 2 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:18 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 9,167 | $1.00 | $9,167.00 |
DisclosureSEC source: 0001217234-20-000061 · wf-form4_158897992025650.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:00 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 5,532 | $22.44 | $124,138.08 |
DisclosureSEC source: 0001217234-20-000041 · wf-form4_158318641892340.xml · nonDerivative · entry 2 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,413 F2 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:00 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001217234-20-000041 · wf-form4_158318641892340.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,945 F1 · shares: The reported securities were represented by restricted performance stock units that were granted on February 4, 2019, 100% of which vested on February 27, 2020 upon the achievement of the requisite performance criteria. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 21:50 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock · Derivative | 30,000 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001217234-20-000019 · wf-form4_158093941254026.xml · derivative · entry 2 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-02-03 F2 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on January 29, 2021 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 21:50 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001217234-20-000019 · wf-form4_158093941254026.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,945 F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on January 29, 2021 and 1/4th of which shall vest on each anniversary thereafter. Read SEC document |
| January 25, 2020 Filed Jan 27, 2020 23:56 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 1,523 | $21.67 | $33,003.41 |
DisclosureSEC source: 0001217234-20-000013 · wf-form4_158016936855256.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,945 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units. Read SEC document |
| January 19, 2020 Filed Jan 21, 2020 23:29 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 1,432 | $23.61 | $33,809.52 |
DisclosureSEC source: 0001702824-20-000002 · wf-form4_157964932270753.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,468 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 20:09 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-021354 · doc4.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,900 F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on August 6, 2020 and 1/4th of which shall vest on each anniversary thereafter. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 21:07 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $12.24 | $0.00 |
DisclosureSEC source: 0000899243-19-017818 · doc4.xml · derivative · entry 11 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 12,500 shares Expires 2028-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on June 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 21:07 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 292 | $0.00 Strike: $6.31 | $0.00 |
DisclosureSEC source: 0000899243-19-017818 · doc4.xml · derivative · entry 10 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,342 Underlying: Common Stock · 292 shares Expires 2028-01-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 21:07 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 937 | $0.00 Strike: $5.90 | $0.00 |
DisclosureSEC source: 0000899243-19-017818 · doc4.xml · derivative · entry 9 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,188 Underlying: Common Stock · 937 shares Expires 2027-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 21:07 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 139 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0000899243-19-017818 · doc4.xml · derivative · entry 8 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,889 Underlying: Common Stock · 139 shares Expires 2027-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: 1/2 of the shares subject to the option vested on September 1, 2018 and 1/72nd of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 21:07 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 834 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0000899243-19-017818 · doc4.xml · derivative · entry 7 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,167 Underlying: Common Stock · 834 shares Expires 2027-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · derivative.exercise_date: 1/4th of the shares subject to the option vested on April 21, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 21:07 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 14,702 | $38.81 | $570,600.79 |
DisclosureSEC source: 0000899243-19-017818 · doc4.xml · nonDerivative · entry 6 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,900 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.76 to $40.49, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 21:07 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 12,500 | $12.24 | $153,000.00 |
DisclosureSEC source: 0000899243-19-017818 · doc4.xml · nonDerivative · entry 5 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 21:07 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 292 | $6.31 | $1,842.52 |
DisclosureSEC source: 0000899243-19-017818 · doc4.xml · nonDerivative · entry 4 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.